| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000033836 |
| Receipt No. | R000038592 |
| Official scientific title of the study | Effect of daily intake of the test food on serum lipid levels and body composition |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2018/09/05 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effect of daily intake of the test food on serum lipid levels and body composition | |
| Title of the study (Brief title) | Effect of the test food intake on serum lipid levels and body composition | |
| Region |
|
|
| Condition | ||
| Condition | Body mass index (BMI): above 25 and less than 30 adult men and women | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To estimate the effect of the test food on serum lipid levels and body composition |
| Basic objectives2 | Others |
| Basic objectives -Others | Timing: Pre-health check/after 8w feeding
Inquiry (Inquiry, Blood pressure, pulsation, Weight, Fat %) Analysis of urine (Urinary protein, sugar, urobilinogen, ALB, AST(GOT), ALT(GPT), LDH, T-Bil, ALP, gamma-GTP, CPK, Ca, Fe, Mg, T-cho, LDL-C, HDL-C, TG, GLC(GLU), HbA1c(NGSP) General blood check (leucocyte, erythrocyte, hemoglobin, Hematocrit, blood platelet) Thyroid function tests : FT3, FT4, TSH # of blood sampling: 1 blood sample/ period Timing of blood sampling: 0W/ 8W |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Visceral fat area |
| Key secondary outcomes | Serum lipids (total cholesterol, LDL-cholesterol, Triglyceride), Body weight, Body mass index (BMI), Body composition |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Non powdered kelp contains maltitol and crystalline cellulose.
Ten tablets x 3times / day during meal Feeding period; 8 weeks |
|
| Interventions/Control_2 | Powdered kelp: One tablet contains 196.7mg of powdered kelp.
Powdered kelp 0.11g / tablet as dietary fiber. Key alginate contains 101mg / tablet, Iodine contains 0.0387mg / tablet (1.16mg / day; less than 3mg / day of tolerable upper intake level). Ten tablets x 3times / day during meal Feeding period: 8 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Basically healthy person
Body mass index (BMI) is above 25 and less than 30. |
|||
| Key exclusion criteria | (1) The person with severe disease in the liver, kidney, heart, lung, digestive organs, blood, endocrine, and urology.
(2) The person who is undergoing therapeutic treatment or take a drug at the time of informed consent agreement. (3) Person having food or drug allergy, hypersensitivity, or those medical history. (4) Person who cannot eat kelp (5) Person who eats FOSHU, Foods with Function Claims, Supplement, So-called health food rich in dietary fiber daily. (6) Person who is controlled or limited iodine intake. (7) Person who drinks excessive alcohol (above 30g/day as alcohol). (8) Person with abnormal food habit or irregular life style such as shifts workers or late-night workers. (9) Person participating in an examination to apply an intake of other food and the examination using the drug, person with the intention of the participation within 4 weeks or after informed consent agreement of present test. (10) Men who carried out the whole blood donation of 400ml from start of this test three months ago. (11) Women who carried out the whole blood donation of 400ml from start of this test four months ago. (12) Person who judged an examination responsibility doctor to be inappropriate as a subject |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Seiichiro Aoe |
| Organization | Otsuma Women's University |
| Division name | Faculty of Home Economics Department Food Science |
| Address | 12 Sanban-cho,Chiyoda-ku,Tokyo |
| TEL | +81-3-5275-6048 |
| s-aoe@otsuma.ac.jp | |
| Public contact | |
| Name of contact person | Seiichiro Aoe |
| Organization | Otsuma Women's University |
| Division name | Faculty of Home Economics Department Food Science |
| Address | 12 Sanban-cho, Chiyoda-ku, Tokyo 102-8357, Japan |
| TEL | +81-3-5275-6048 |
| Homepage URL | |
| s-aoe@otsuma.ac.jp | |
| Sponsor | |
| Institute | Seiichiro Aoe
Otsuma Women's University Faculty of Home Economics Department Food Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokkaido Federation of Fisheries Associations |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Maruyanagi Foods Inc. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大妻女子大学(東京都)/Otsuma Women’s university (Tokyo)
CPCC株式会社/CPCC Company Limited |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038592 |